A Multidimensional Meta-Analysis of Pharmacotherapy for Bulimia Nervosa: Summarizing the Range of Outcomes in Controlled Clinical Trials

REFERENCES

• Agras WS, McCann U. The efficacy and role of antidepressants in the treatment of bulimia nervosa. Ann Behav Med 1987; 9:18–22.
   Google Scholar
• Mayer LES, Walsh BT. The use of selective serotonin reuptake inhibitors in eating disorders. J Clin Psychiatry 1998;59(suppl 15):28–34.
   Google Scholar
• Mitchell PB. The pharmacological management of bulimia ner- vosa: a critical review. Int J Eat Disord 1988;7:29–41.
   Google Scholar
• Pope HG Jr, Hudson JI. Antidepressant drug therapy for bu- limia: current status. J Clin Psychiatry 1986;47:339–45.
   Google Scholar
• Walsh BT. Antidepressants and bulimia: where are we? Int J Eat Disord 1988;7:421–3.
   Google Scholar
• Walsh BT. Pharmacological treatment. In: Halmi KA, ed. Psy- chobiology and treatment of anorexia nervosa and bulimia nervosa. Washington, DC: American Psychiatric Press, 1992: 329–40.
   Google Scholar
• Jimerson DC, Wolfe BE, Brotman AW, Metzger ED. Medications in the treatment of eating disorders. Psychiatr Clin North Am 1996;19:739–54.
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, Hudson JI. Antidepressant medication in the treat- ment of bulimia nervosa. Psychopathology 1987;20(suppl 1): 123–9.
   Google Scholar
• Agras WS. Pharmacotherapy of bulimia nervosa and binge eating disorder: longer-term outcomes. Psychopharmacol Bull 1997;33:433–6.
   PubMed Web of Science ®Google Scholar
• Bacaltchuk J, Trefiglio RP, De Oliveira IR, Lima MS, Mari JJ. Antidepressants versus psychotherapy for bulimia nervosa: a systematic review. J Clin Pharm Ther 1999;24:23–31.
   PubMedGoogle Scholar
• Freeman CPL, Munro JKM. Drug and group treatments for bulimia/bulimia nervosa. J Psychosom Res 1988;32:647–60.
   PubMed Web of Science ®Google Scholar
• Leach AM. The psychopharmacotherapy of eating disorders. Psychiatr Ann 1995;25:628–33.
   Google Scholar
• Whittal ML, Agras WS, Gould RA. Bulimia nervosa: a meta- analysis of psychosocial and pharmacological treatments. Be- hav Ther 1999;30:117–35.
   Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for eating disorders. Am J Psychiatry 1993;150:212–28.
   Google Scholar
• Freeman C. Drug treatment for bulimia nervosa. Neuropsycho- biology 1998;37:72–9.
   PubMed Web of Science ®Google Scholar
• Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empiri- cally supported therapies. J Consult Clin Psychol 2001;69:875–99.
   PubMed Web of Science ®Google Scholar
• Rosenthal R. Meta-analytic procedures for social research. Re- vised ed. Thousand Oaks, California: Sage, 1991.
   Google Scholar
• Rosenthal R. Writing meta-analytic reviews. Psychol Bull 1995; 118:183–92.
   Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, New Jersey: Erlbaum, 1988.
   Google Scholar
• Jacobson NJ, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treat- ment effects: description, application, and alternatives. J Con- sult Clin Psychol 1999;67:300–7.
   PubMed Web of Science ®Google Scholar
• Jacobson NS, Truax P. Clinical significance: a statistical ap- proach to defining meaningful change in psychotherapy re- search. J Consult Clin Psychol 1991;59:12–9.
   PubMed Web of Science ®Google Scholar
• Kendall PC, Marrs-Garcia A, Nath SR, Sheldrick RC. Normative comparisons for the evaluation of clinical significance. J Consult Clin Psychol 1999;67:285–99.
   PubMed Web of Science ®Google Scholar
• Kendall PC, Sheldrick RC. Normative data for normative com- parisons. J Consult Clin Psychol 2000;68:767–73.
   PubMed Web of Science ®Google Scholar
• Kendall PC, Flannery-Schroeder EC, Ford JD. Therapy outcome research methods. In: Kendall PC, Butcher JN, Holmbeck GN, eds. Handbook of research methods in clinical psychology. 2nd ed. New York: Wiley, 1999:330–63.
   Google Scholar
• Herzog DB, Dorer DJ, Keel PK, Selwyn SE, Ekeblad ER, Flores AT, et al. Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow-up study. J Am Acad Child Adolesc Psychiatry 1999;38:829–37.
   Google Scholar
• Keel PK, Mitchell JE. Outcome in bulimia nervosa. Am J Psychi- atry 1997;154:313–21.
   PubMed Web of Science ®Google Scholar
• Rossiter EM, Agras WS, Telch CF, Schneider JA. Cluster B per- sonality disorder characteristics predict outcome in the treat- ment of bulimia nervosa. Int J Eat Disord 1993;13:349–57.
   PubMed Web of Science ®Google Scholar
• Rossiter EM, Agras WS, Losch M. Changes in self-reported food intake in bulimics as a consequence of antidepressant treat- ment. Int J Eat Disord 1988;7:779–83.
   Google Scholar
• Ong YL, Checkley SA, Russell GFM. Suppression of bulimic symptoms with methylamphetamine. Br J Psychiatry 1983; 143:288–93.
   PubMed Web of Science ®Google Scholar
• Hsu LG. Treatment of bulimia with lithium. Am J Psychiatry 1984;141:1260–2.
   PubMed Web of Science ®Google Scholar
• Greenberg RP, Bornstein RF, Greenberg MD, Fisher S. A meta- analysis of antidepressant outcome under “blinder” conditions. J Consult Clin Psychol 1992;60:664–9.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rounsaville BJ, Nich C. Blind man’s bluff: effective- ness and significance of psychotherapy and pharmacotherapy blinding procedures in a clinical trial. J Consult Clin Psychol 1994;62:276–80.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
   Google Scholar
• Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The Eating Atti- tudes Test: psychometric features and clinical correlates. Psy- chol Med 1982;12:871–8.
   PubMed Web of Science ®Google Scholar
• Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, et al. One-year follow-up of psychosocial and pharmoco- logic treatments for bulimia nervosa. J Clin Psychiatry 1994;55:179–83.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Long- term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991;148:1206–12.
   PubMed Web of Science ®Google Scholar
• Pyle RL, Mitchell JE, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment. Am J Psy- chiatry 1990;147:871–5.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, et al. A trial of isocarboxazid in the treatment of bu- limia nervosa. J Clin Psychopharmacol 1988;8:391–6.
   PubMed Web of Science ®Google Scholar
• Blouin AG, Blouin JH, Perez EL, Bushnik T, Zuro C, Mulder E. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988;8:261–9.
   PubMed Web of Science ®Google Scholar
• Blouin JH, Blouin AG, Perez EL, Barlow J. Bulimia: independ- ence of antibulimic and antidepressant properties of desipra- mine. Can J Psychiatry 1989;34:24–9.
   Google Scholar
• Johnson C, Tobin DL, Dennis A. Differences in treatment out- come between borderline and nonborderline bulimics at one- year follow-up. Int J Eat Disord 1990;9:617–27.
   Web of Science ®Google Scholar
• Mitchell JE, Maki DD, Adson DE, Ruskin BS, Crow S. The selec- tivity of inclusion and exclusion criteria in bulimia nervosa treatment studies. Int J Eat Disord 1997;22:243–52.
   PubMed Web of Science ®Google Scholar
• Laessle RG, Zoettl C, Pirke KM. Metaanalysis of treatment studies for bulimia. Int J Eat Disord 1987;6:647–53.
   Web of Science ®Google Scholar
• Mitchell JE, Tareen B, Sheehan W, Agras S, Brewerton TD, Crow S, et al. Establishing guidelines for pharmacotherapy tri- als in bulimia nervosa and anorexia nervosa. Int J Eat Disord 2000;28:1–7.
   PubMed Web of Science ®Google Scholar
• Egger M, Jüni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA 2001;285:1996–9.
   PubMed Web of Science ®Google Scholar
• Agras WS, Dorian B, Kirkley BG, Arnow B, Bachman J. Imipramine in the treatment of bulimia: a double-blind con- trolled study. Int J Eat Disord 1987;6:29–38.
   Web of Science ®Google Scholar
• Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Rae- burn SD, et al. Pharmacologic and cognitive-behavioral treat- ment for bulimia nervosa: a controlled comparison. Am J Psychi- atry 1992;149:82–7.
   Google Scholar
• Beumont PJV, Russell JD, Touyz SW, Buckley C, Lowinger K, Talbot P, et al. Intensive nutritional counselling in bulimia ner- vosa: a role for supplementation with fluoxetine? Aust NZ J Psy- chiatry 1997;31:514–24.
   PubMed Web of Science ®Google Scholar
• Fahy TA, Eisler I, Russell GFM. A placebo-controlled trial of d- fenfluramine in bulimia nervosa. Br J Psychiatry 1993;162:597–603.
   PubMed Web of Science ®Google Scholar
• Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Phar- macopsychiatry 1991;24:1–7.
   PubMed Web of Science ®Google Scholar
• Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluox- etine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139–47.
   Google Scholar
• Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. Behav Res Ther 1997;35:803–11.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166:660–6.
   PubMed Web of Science ®Google Scholar
• Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, et al. Treatment of bulimia with bupropion: a multi- center controlled trial. J Clin Psychiatry 1988;49:262–6.
   PubMed Web of Science ®Google Scholar
• Hsu LG, Clement L, Santhouse R, Ju ES. Treatment of bulimia nervosa with lithium carbonate: a controlled study. J Nerv Ment Disord 1991;179:351–5.
   PubMed Web of Science ®Google Scholar
• Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM. Treating bulimia nervosa with desipramine: a double blind, placebo con- trolled study. Arch Gen Psychiatry 1986:43:182–6.
   Google Scholar
• Kanerva R, Rissanen A, Sarna S. Fluoxetine in the treatment of anxiety, depressive symptoms, and eating-related symptoms in bulimia nervosa. Nord J Psychiatry 1995;49:237–42.
   Web of Science ®Google Scholar
• Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D’Souza JD, Lofchy J. Is there a role for selective monoamine oxidase in- hibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol 1993;13:415–22.
   PubMed Web of Science ®Google Scholar
• Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984;4:186–93.
   PubMed Web of Science ®Google Scholar
• Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990;47:149–57.
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983;140:554–8.
   Google Scholar
• Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. A placebo- controlled study of trazodone in bulimia nervosa. J Clin Psy- chopharmacol 1989;9:254–9.
   Google Scholar
• Walsh BT, Gladis M, Roose SP, Stewart JW, Stetner F, Glassman AH. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988;45:471–5.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Stewart JW, Roose SP, Gladis M, Glassman AH. A double-blind trial of phenelzine in bulimia. J Psychiatr Res 1985;19:485–9.
   PubMedGoogle Scholar
• Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997;154:523–31.
   PubMed Web of Science ®Google Scholar
• Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ. Effect of a tricyclic antidepressant and opiate an- tagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 1991;53:865–71.
   PubMed Web of Science ®Google Scholar
• Ayuso-Gutierrez JL, Palazón M, Ayuso-Mateos JL. Open trial of fluvoxamine in the treatment of bulimia nervosa. Int J Eat Dis- ord 1994;15:245–9.
   PubMed Web of Science ®Google Scholar
• Barlow J, Blouin JH, Blouin AG, Perez E. Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychi- atry 1988;33:129–33.
   PubMed Web of Science ®Google Scholar
• Bossert S, Schmölz U, Wiegand M, Junker M, Krieg JC. Predic- tors of short-term treatment outcome in bulimia nervosa inpa- tients. Behav Res Ther 1992;30:193–9.
   PubMedGoogle Scholar
• Brambilla F, Draisci A, Peirone A, Brunetta M. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa. Neuropsychobiology 1995;32:68–71.
   PubMed Web of Science ®Google Scholar
• Brotman AW, Herzog DB, Woods SW. Antidepressant treatment of bulimia: the relationship between bingeing and depressive symptomatology. J Clin Psychiatry 1984;45:7–9.
   PubMed Web of Science ®Google Scholar
• Collings S, King M. Ten-year follow-up of 50 patients with bu- limia nervosa. Br J Psychiatry 1994;164:80–7.
   PubMed Web of Science ®Google Scholar
• Crane RA, Raskin V, Weiler M, Perri J. Nomifensine treatment of bulimia: results of an open trial. Int J Eat Disord 1987; 6:427–30.
   Google Scholar
• Fallon BA, Walsh BT, Sadik C, Saoud JB, Lukasik V. Outcome and clinical course in inpatient bulimic women: a 2- to 9-year follow-up study. J Clin Psychiatry 1991;52:272–8.
   PubMed Web of Science ®Google Scholar
• Fava M, Herzog DB, Hamburg P, Riess H, Anfang S, Rosenbaum JF. Long-term use of fluoxetine in bulimia nervosa: a retrospec- tive study. Ann Clin Psychiatry 1990;2:53–6.
   Google Scholar
• Fichter MM, Krüger R, Rief W, Holland R, Döhne J. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating- specific psychopathology. J Clin Psychopharmacol 1996;16:9–18.
   PubMed Web of Science ®Google Scholar
• Geretsegger C, Greimel KV, Roed IS, Keppel-Hesselink JM. Ip- sapirone in the treatment of bulimia nervosa: an open pilot study. Int J Eat Disord 1995;17:359–63.
   PubMedGoogle Scholar
• Hudson JI, Pope HG Jr, Jonas JM. Antidepressant treatment of bulimia. Adv Behav Res Ther 1985;7:173–9.
   Google Scholar
• Hudson JI, Pope HG Jr, Jonas JM. Treatment of bulimia with antidepressants: theoretical considerations and clinical find- ings. Psychiatr Ann 1983;13:965–9.
   Web of Science ®Google Scholar
• Joja O, Goldstein R, Popa M. Vasotocin effects in depressive pa- tients with eating disorders. Rom J Endocrinol 1993;31:171–7.
   PubMedGoogle Scholar
• Jonas JM, Gold MS. Treatment of antidepressant-resistant bu- limia with naltrexone. Int J Psychiatry Med 1986–87;16:305–9.
   Google Scholar
• Jonas JM, Gold MS. The use of opiate antagonists in treating bu- limia: a study of low-dose versus high-dose naltrexone. Psychia- try Res 1988;24:195–9.
   PubMed Web of Science ®Google Scholar
• Kaplan AS, Garfinkel PE, Darby PL, Garner DM. Carba- mazepine in the treatment of bulimia. Am J Psychiatry 1983; 140:1225–6.
   PubMed Web of Science ®Google Scholar
• Keel PK, Mitchell JE, Miller KB, Davis TL, Crow SJ. Long-term outcome of bulimia nervosa. Arch Gen Psychiatry 1999;56:63–9.
   PubMed Web of Science ®Google Scholar
• Krahn D, Mitchell J. Use of L-tryptophan in treating bulimia [Letter]. Am J Psychiatry 1985;142:1130.
   PubMed Web of Science ®Google Scholar
• Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebnik D. Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Behav Res Ther 1994;32:37–45.
   PubMed Web of Science ®Google Scholar
• Marrazzi MA, Bacon JP, Kinzie J, Luby ED. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995;10:163–72.
   PubMed Web of Science ®Google Scholar
• McCann UD, Agras WS. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo- controlled study. Am J Psychiatry 1990;147:1509–13.
   PubMed Web of Science ®Google Scholar
• Mitchell JE, Davis L, Goff G, Pyle R. A follow-up study of pa- tients with bulimia. Int J Eat Disord 1986;5:441–50.
   Web of Science ®Google Scholar
• Mitchell JE, Christenson G, Jennings J, Huber M, Thomas B, Pomeroy C, et al. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. J Clin Psychopharmacol 1989;9:94–7.
   PubMed Web of Science ®Google Scholar
• Robinson PH, Checkley SA, Russell GFM. Suppression of eating by fenfluramine in patients with bulimia nervosa. Br J Psychia- try 1985;146:169–76.
   PubMed Web of Science ®Google Scholar
• Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek- Welikson K, McGrath PJ, et al. A double-blind placebo-con- trolled comparison of phenelzine and imipramine in the treat- ment of bulimia in atypical depressives. Int J Eat Disord 1994; 15:1–9.
   PubMed Web of Science ®Google Scholar
• Sabine EJ, Yonace A, Farrington AJ, Barratt KH, Wakeling A. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol 1983;15(suppl 2): 195–202S.
   Google Scholar
• Stewart JW, Walsh BT, Wright L, Roose SP, Glassman AH. An open trial of MAO inhibitors in bulimia. J Clin Psychiatry 1984; 45:217–9.
   Google Scholar
• Trygstad O. Drugs in the treatment of bulimia nervosa. Acta Psychiatr Scand Suppl 1990;361:34–7.
   Google Scholar
• Walsh BT, Stewart JW, Wright L, Harrison W, Roose SP, Glass- man AH. Treatment of bulimia with monoamine oxidase in- hibitors. Am J Psychiatry 1982;139:1629–30.
   Google Scholar
• Walsh BT, Stewart JW, Roose SP, Gladis M, Glassman AH. Treatment of bulimia with phenelzine: a double-blind placebo- controlled study. Arch Gen Psychiatry 1984;41:1105–9.
   PubMed Web of Science ®Google Scholar
• Wold P. Trazodone in the treatment of bulimia [Letter]. J Clin Psychiatry 1983;44:275–6.
   Google Scholar